4.6 Article

Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pathology

MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice

Paola Parente et al.

Summary: This study assessed the concordance rate of MMR/MSI status between primary mucinous adenocarcinoma (MA) and synchronous metastasis. The results showed high concordance rates using different evaluation methods. Therefore, integrating immunohistochemistry evaluation and molecular methods may be beneficial for molecular profiling of MA patients.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Review Oncology

Mismatch repair deficiency: The what, how and why it is important

Maria C. Olave et al.

Summary: The mismatch repair system is crucial for maintaining genomic integrity, with deficiencies leading to hypermutability and microsatellite instability. Detection of these deficiencies is used for diagnostic, predictive, and prognostic purposes. Microsatellite instability can be evaluated through PCR or immunohistochemistry to assess mismatch repair function.

GENES CHROMOSOMES & CANCER (2022)

Article Pathology

Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing

Marie C. Smithgall et al.

Summary: In gynecologic cancers, 98.2% of cases showed concordance between IHC and MSI results, with 6 discrepant cases identified. The use of NGS helped in resolving these discrepancies, highlighting the importance of selecting appropriate tumor tissue for testing.

HUMAN PATHOLOGY (2022)

Article Pathology

Comparison of the Idylla (TM) MSI assay with the Promega (TM) MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study

Sonia Gatius et al.

Summary: The determination of microsatellite instability (MSI) and mismatch repair deficiency (MMRD) is crucial for the diagnosis and prognosis of endometrial carcinomas (ECs), identification of Lynch syndrome carriers, and selection of patients for immunotherapy. The Idylla(TM) MSI assay is a rapid and highly concordant test for MSI in EC. It does not require non-tumoral tissue and can be performed in about 150 min.

VIRCHOWS ARCHIV (2022)

Article Pathology

An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes

Marion Jaffrelot et al.

Summary: This study established a classification of unusual MMR-D tumors, with 15% of MMR-D tumors identified as unusual and showing a high frequency of TMB-high or -intermediate and genetic syndromes. Patients with unusual MMR-D tumors who received immune checkpoint inhibitor treatment had prolonged clinical benefit.

MODERN PATHOLOGY (2022)

Article Cell Biology

Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series

Maurice B. Loughrey et al.

Summary: This study compared PCR-based microsatellite instability (MSI) testing and MMR protein immunohistochemistry (IHC) in colorectal cancer cases and found that both methods are equally proficient in establishing MMR/MSI status, but awareness of potential pitfalls is important. The choice of methodology may depend on available services and expertise.

HISTOPATHOLOGY (2021)

Article Multidisciplinary Sciences

Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors

Keitaro Shimozaki et al.

Summary: The study found that NGS and PCR methods showed good concordance in the positive and negative predictive values for detecting MSI-H/dMMR, with NGS also demonstrating potential applications in clinical practice.

SCIENTIFIC REPORTS (2021)

Article Oncology

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

Jian Xiao et al.

Summary: The integration of MSI and TMB information is crucial for predicting immune checkpoint inhibitors efficacy in colorectal cancer, demonstrating the importance of comprehensive molecular diagnosis using NGS panel-based method.

BMC CANCER (2021)

Article Pathology

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer

Iiris Ukkola et al.

Summary: Universal testing of microsatellite instability (MSI) is recommended for colorectal cancer (CRC) and endometrial cancer (EC) to screen for Lynch syndrome and to aid in assessing prognosis and optimal treatment. The Idylla MSI test offers a sensitive and specific method for CRC diagnostics but is less sensitive in EC samples, especially in the case of MSH6 deficiency.

VIRCHOWS ARCHIV (2021)

Article Oncology

Original Research Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study

Carlotta Antoniotti et al.

Summary: This study conducted comprehensive genomic profiling of tumour samples from metastatic colorectal cancer patients, revealing a strong association between high TMB and MSI-H, and suggested an optimal threshold of 17 mut/Mb for predicting MSI status. Additionally, actionable mutations were identified in 21% of the patients.

EUROPEAN JOURNAL OF CANCER (2021)

Article Cell Biology

Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting

Umberto Malapelle et al.

Summary: Immune-checkpoint inhibitors have shown efficacy in treating advanced stage colorectal cancer and other solid tumors with deficient DNA mismatch repair or high microsatellite instability status. Molecular techniques, such as Idylla(TM) MSI test and TapeStation 4200, play a central role in evaluating dMMR/MSI-H status in various types of solid tumors, not just in CRC patients.
Article Oncology

Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer

A. Guyot D'Asnieres De Salins et al.

Summary: The study confirmed a high degree of concordance between MSI and MMR IHC tests, emphasizing the importance of reviewing discordant cases and analysis by expert teams.

ESMO OPEN (2021)

Article Medical Laboratory Technology

Microsatellite instability status is determined by targeted sequencing with MSIcall in 25 cancer types

Yosuke Hirotsu et al.

CLINICA CHIMICA ACTA (2020)

Article Multidisciplinary Sciences

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le et al.

SCIENCE (2017)

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Biochemistry & Molecular Biology

Association Between IHC and MSI Testing to Identify Mismatch Repair-Deficient Patients with Ovarian Cancer

Ji-Hyun Lee et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)

Article Oncology

Cancer risk in Lynch Syndrome

Emma Barrow et al.

FAMILIAL CANCER (2013)

Review Oncology

Systematic review of microsatellite instability and colorectal cancer prognosis

S Popat et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Biotechnology & Applied Microbiology

Development of a fluorescent multiplex assay for detection of MSI-high tumors

JW Bacher et al.

DISEASE MARKERS (2004)

Article Pathology

Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction

KD Berg et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2000)